Survivorship

2022 BURST Year in Review™: Reflecting on Recent Evidence for Testing in Patients with GI Cancers

2nd Annual International Congress on Pediatric Oncology

2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

PER's Breast Cancer Symposia in San Antonio

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

9th Annual School of Gastrointestinal Oncology® (SOGO®)

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

New Targets, New Treatments, and New Combinations for the Management of Advanced Prostate Cancer

BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS

BURST CME™: What Is the Real Risk in Lower-Risk MDS?

BURST CME™: How Does Transfusion Burden Impact Real-World Outcomes in MDS?

Advances In™ KRAS Inhibition: Modern Considerations In Targeting KRAS-Mutated Lung, Colorectal, And Pancreatic Cancers

How We Do It™: Integrating Gene Fusion Testing in Oncology Clinics for Patients with NSCLC

The Latest on Acute Lymphocytic Leukemia

Updates in Myelodysplastic Syndromes

A Focus on Acute Myeloid Leukemia

Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community

Medical Crossfire®: Key Strategies to Prioritize Testing and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care

Community Practice Connections™: The Newest Frontier in HR+ Breast Cancer—Targeting ESR1 Mutations with Next-Generation Endocrine Therapy

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

Medical Crossfire™: How Do We Implement Personalized Treatment for Colorectal Cancer in the Community?

Medical Crossfire®: Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

Medical Crossfire®: Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

Live “Hot Seat”: Experts Face Your Hot-Button Questions on Maximizing PARP Inhibitors in Patients With CRPC

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

Medical Crossfire®: Exploring Hot Topics in DLBCL: Sequencing CD19-Targeted Therapies, Strategies Post-CAR T Relapse, Novel Agents, and More!